Alliança Saúde e Participações S.A. has announced the acquisition of 100% of CURA's diagnostic and clinical analysis operations in São Paulo to enhance its service offerings and drive sustainable growth.

Target Information

ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. (referred to as "Alliança"), listed on B3 under the ticker AALR3, has announced it signed a "Contract for Purchase and Sale of Shares and Other Agreements" on February 21, 2025, to acquire 100% of the diagnostic imaging and clinical analysis operations in São Paulo, conducted by the esteemed brand Cura. This acquisition involves the complete purchase of CURA – Centro de Ultrassonografia e Radiologia S.A., which is currently owned by Refuá Participações S.A.

This transaction is aligned with Alliança's sustainable growth strategy and represents the acquisition of the well-established Cura brand, which has over 40 years of experience in high-quality diagnostic medicine, leveraging advanced technology and artificial intelligence solutions. Importantly, this acquisition will enhance Alliança's operational presence in São Paulo, thus increasing its clinical analysis revenue and ability to conduct high-complexity imaging examinations, such as MRI and CT scans. Additionally, it marks Alliança's first operation in São Paulo focused on female health services, presenting a projected increase of approximately R$80,000,000.00 to Alliança's gross operational revenue.

Industry Overview

The healthcare sector in Brazil has been undergoing significant transformations, particularly in major urban centers like São Paulo. With the increasing demand for advanced medical diagnostics and the integration of technology into healthcare process